Merzak A, Koochekpour S, Pilkington G J
Department of Neuropathology, Institute of Psychiatry, London, UK.
Cell Adhes Commun. 1995 Feb;3(1):27-43. doi: 10.3109/15419069509081276.
Adhesion of eight cell lines, derived from human gliomas of different histological types, to fibronectin, collagen I, vitronectin, and laminin was investigated in vitro. The glioma cell lines were found to attach to these substrates to different extents. Interestingly, all cell lines strongly attached to laminin. In addition, glioma cell adhesion was found to be dose dependent. Moreover, adhesion of three cell lines to fibronectin and collagen I was partially inhibited and to vitronectin completely prevented by GRGDTP peptide, indicating the involvement of integrin receptors in glioma cell adhesion. We have demonstrated, recently, that gangliosides play an important role in promoting glioma cell invasion of the reconstituted basement membrane, Matrigel, in vitro. In order to study the mechanism of action of gangliosides in this process, the role of six gangliosides (GM1, GM3, GD3, GD1a, GD1b, and GT1b) in cell adhesion to the four proteins was investigated in three cell lines. Although all gangliosides, with the exception of GM3, were found to enhance cell adhesion to these proteins to different extents, GD3 proved to be the most effective adhesion-promoting ganglioside in all three cell lines. GM3 was found to inhibit cell adhesion to the four proteins in one cell line but enhanced cell adhesion in two other cell lines. The three cell lines were found to express both GD3 and gangliosides recognised by the A2B5 antibody. Furthermore, adhesion of the three cell lines to fibronectin, vitronectin, laminin, and collagen I was inhibited by incubation with A2B5, demonstrating the involvement of intrinsic cell membrane gangliosides in adhesion of glioma cells to these proteins. Taken together with the observation that gangliosides modulate integrin receptor function, these data suggest that gangliosides may play a central role in the control of the adhesive and invasive properties of human glioma cells.
体外研究了源自不同组织学类型人脑胶质瘤的8种细胞系对纤连蛋白、I型胶原、玻连蛋白和层粘连蛋白的黏附情况。发现胶质瘤细胞系对这些底物的黏附程度各不相同。有趣的是,所有细胞系都强烈黏附于层粘连蛋白。此外,发现胶质瘤细胞的黏附呈剂量依赖性。而且,GRGDTP肽部分抑制了三种细胞系对纤连蛋白和I型胶原的黏附,并完全阻止了其对玻连蛋白的黏附,表明整合素受体参与了胶质瘤细胞的黏附。我们最近证明,神经节苷脂在体外促进胶质瘤细胞侵袭重组基底膜基质胶的过程中起重要作用。为了研究神经节苷脂在此过程中的作用机制,在三种细胞系中研究了六种神经节苷脂(GM1、GM3、GD3、GD1a、GD1b和GT1b)对这四种蛋白质的细胞黏附作用。尽管发现除GM3外的所有神经节苷脂都能不同程度地增强细胞对这些蛋白质的黏附,但GD3被证明是所有三种细胞系中最有效的促进黏附的神经节苷脂。发现GM3在一种细胞系中抑制细胞对这四种蛋白质的黏附,但在另外两种细胞系中增强细胞黏附。发现这三种细胞系都表达GD3和A2B5抗体识别的神经节苷脂。此外,用A2B5孵育可抑制这三种细胞系对纤连蛋白、玻连蛋白、层粘连蛋白和I型胶原的黏附,表明细胞膜内源性神经节苷脂参与了胶质瘤细胞对这些蛋白质的黏附。结合神经节苷脂调节整合素受体功能的观察结果,这些数据表明神经节苷脂可能在控制人胶质瘤细胞的黏附性和侵袭性方面发挥核心作用。